Site maintenance Wednesday, November 13th, 2024. Please note that access to some content and account information will be unavailable on this date.
Skip to main content
Full access
Articles
Published Online: 1 December 2014

Comorbid Depression and Substance Abuse Among Safety-Net Clients in Los Angeles: A Community Participatory Study

Abstract

Objective:

Depression and substance abuse are common among low-income adults from racial-ethnic minority groups who receive services in safety-net settings, although little is known about how clients differ by service setting. This study examined characteristics and service use among depressed, low-income persons from minority groups in underresourced communities who did and did not have a substance abuse history.

Methods:

The study used cross-sectional baseline client data (N=957) from Community Partners in Care, an initiative to improve depression services in Los Angeles County. Clients with probable depression (eight-item Patient Health Questionnaire) from substance abuse programs were compared with depressed clients with and without a history of substance abuse from primary care, mental health, and social and community programs. Sociodemographic, health status, and services utilization variables were examined.

Results:

Of the 957 depressed clients, 217 (23%) were from substance abuse programs; 269 (28%) clients from other sectors had a substance abuse history, and 471 (49%) did not. Most clients from substance abuse programs or with a substance abuse history were unemployed and impoverished, lacked health insurance, and had high rates of arrests and homelessness. They were also more likely than clients without a substance abuse history to have depression or anxiety disorders, psychosis, and mania and to use emergency rooms.

Conclusions:

Clients with depression and a substance abuse history had significant psychosocial stressors and high rates of service use, which suggests that communitywide approaches may be needed to address both depression and substance abuse in this safety-net population.
Comorbid depression and substance abuse are common among low-income adults in minority communities (15). These individuals’ health care is often uncoordinated and of variable quality and high cost (6). Prior work has shown substantial unmet need among clients with comorbid depression and substance abuse in safety-net primary care, mental health, substance abuse, and social services sectors (1,617). Depending on the sector, this population may receive screening, treatment, or referral for either depression or substance abuse, but rarely for both (1821). Few reports describe individuals with comorbidities across sectors (primary care, mental health, substance abuse, and social services). However, such data may inform the implementation of Medicaid behavioral health homes (2224) and integrated care models (2432).
This cross-sectional, exploratory study described demographic and clinical characteristics and services use for depressed adult clients with and without a history of substance abuse who were served in diverse service sectors. The goal was to support agencies in underresourced communities with program planning. With input from partner agencies, we defined a client with a comorbid substance abuse history as either a depressed person who received services in a substance abuse agency or as a depressed person who received services in other health care or community sectors and who had recent substance abuse, substance dependence, or use of substance abuse services. This broad definition is relevant for services planning. The study questions were as follows: How common is a substance abuse history among depressed clients of diverse community-based sectors? How similar are depressed clients in substance abuse programs and depressed clients with a recent substance abuse history in other community sectors? In non–substance abuse sectors, how do depressed clients with and without a recent substance abuse history differ in health status and services utilization? How satisfied with community mental health services are depressed clients with and without a substance abuse history?

Methods

The study used baseline client data from Community Partners in Care (CPIC) (33,34), a group-level, randomized comparative effectiveness trial to improve depression services in Los Angeles. CPIC was implemented by using community-partnered participatory research (35,36), which emphasizes power sharing and joint planning among academic and community partners in all research phases. The lead community partners for these analyses were Behavioral Health Services and Los Angeles Christian Health Center. Institutional review boards at RAND and at participating agencies approved all study procedures. The study design has been described elsewhere (33,34,37,38). [A figure in the online data supplement to this article illustrates agency, program, and participant enrollment.]

Communities

South Los Angeles (SLA) (1.5 million people) and Hollywood-Metro (HM) (500,000 people) were selected by convenience on the basis of established partnerships (39,40). SLA and HM are geographically defined, Los Angeles County service planning areas (41,42). Community stakeholders nominated service sectors important for depressed clients (33) and prioritized populations for oversampling. SLA nominated substance abuse clients and African Americans, and HM nominated homeless persons and seniors.

Participating Agencies

County directories were combined with community nominations to identify agencies in five sectors: outpatient primary care and public health, outpatient mental health, substance abuse (residential and outpatient), social and housing services, and other social and community-based services (for example, family preservation, prisoner reentry, senior centers, hair salons, exercise clubs, parks, and churches). Eligible agencies provided services for adults or for parents of child clients and were expected to continue operations over the study period. Of 149 agencies approached for participation, 50 agreed, 47 refused, 33 were ineligible, and 19 were unreachable and lost to follow-up. Participating and nonparticipating agencies were comparable in average household characteristics (age, sex, race-ethnicity, population density, and income) by zip code (37).

Programs

Fifty agencies had 122 programs, of which 16 were ineligible, 11 declined, and 95 enrolled. Eligible programs served 15 or more clients per week, had at least one staff member, were financially stable, and were not exclusively focused on psychotic disorders or home services. At two programs, no clients were screened, which left a total of 93 programs.

Clients

Within programs, consecutive clients were screened in waiting rooms or at events from March to November 2010. Over the course of two or three days at each program, RAND survey staff approached 4,649 adults (age ≥18 and English or Spanish speaking); of these, 4,440 clients were screened. Of those screened, 3,118 were ineligible: 153 did not provide contact information, and 2,965 were not depressed as defined by a score <10 on the eight-item Patient Health Questionnaire (PHQ-8) with and without the word “depression,” based on community input (Pearson correlation coefficient of the standard and community-modified versions was .99). The PHQ-8 has the same scoring characteristics and cut-point as the PHQ-9 (43).
Of 1,322 eligible clients, 1,246 consented. Between April 2010 and January 2011, a total of 981 (74%) of these clients completed baseline telephone surveys with RAND staff. Reasons for noncompletion were as follows: two were deceased, 36 refused, and 227 were unreachable. The response rate of 74% is acceptable for depression quality improvement studies (4447). The analysis included 957 clients with standard PHQ-8 scores of ≥10, indicating moderate to severe depression. We excluded the 24 clients who entered the study because of a positive community-modified PHQ-8 but had a standard PHQ-8 score of <10.

Measures

All measures were client self-report, from instruments administered at the initial screening or from telephone-administered baseline surveys.

Sociodemographic Variables

We assessed age, gender, marital status, family income, education, housing, employment status, and race-ethnicity (Latino, African American, non-Hispanic white, and other) by using screening instruments.

Dependent Variables

Other than PHQ-8 scores, which were assessed at the initial screening, all other dependent variables were from telephone-administered client surveys. Measures of general medical and psychosocial need were as follows: life difficulties (that is, evicted, arrested, or on probation); physical component summary score (PCS-12) and mental component summary score (MCS-12) from the 12-item Short-Form Health Survey (48); probable 12-month major depressive or dysthymic disorder, current manic episode, anxiety disorder (one-month panic or posttraumatic stress disorder or six-month generalized anxiety disorder), and past 12-month alcohol abuse or illicit drug use—all measured using the Mini International Neuropsychiatric Interview (MINI) (49); and alcohol use items from the Alcohol Use Disorders Identification Test (AUDIT-C) (50).
Service utilization measures were length of inpatient or substance abuse rehabilitation stay for alcohol, drug, or mental health problems; emergency room visits for alcohol, drug, or mental or emotional problems; and outpatient visits to mental health providers, social service agencies, faith-based agencies, and parks and community centers six months before the baseline survey. We coded outpatient encounters as depression-related if the client reported that any provider suggested visiting a specialist or a program for depression, taking medications, or staying in treatment for depression or offered at least five minutes of counseling about depression, stress, emotions, or coping strategies.
Binary indicators of satisfaction were constructed: satisfied or very satisfied versus neutral to very dissatisfied with health services and social services available for emotional health concerns.

Independent Variable

Substance abuse history status (three categories) was categorized as being screened in a substance abuse agency, being screened in another sector but having a recent substance abuse history, or being screened in another sector but not having a recent substance abuse history. Recent substance abuse history was defined as any of the following: 12-month substance abuse or substance dependence diagnosis on the basis of the MINI, stayed overnight in an alcohol or drug abuse residential treatment program, or attended any outpatient substance abuse agency or self-help meeting for drug or alcohol use in the past six months.

Covariates

Age and gender were assessed with screening instruments.

Analyses

The distribution of sample characteristics was described by using means and standard deviations for continuous variables and percentages for categorical variables. Each dependent variable was cross-tabulated with substance abuse history status. To examine differences in dependent variables by substance abuse history status, we fit linear regression models for continuous variables, logistic regression models for dichotomous variables, and log-linear models for counts of visits with substance abuse status as the primary predictor adjusted for age and gender. We conducted two pairwise comparisons between clients with and without a recent substance abuse history who were screened in substance abuse agencies versus other community sectors. We present results using standardized predictions with 95% confidence intervals from fitted regression models (51).
To control for potential response bias, attrition weights were constructed by fitting logistic regression models stratified by intervention condition to predict enrollment status and baseline completion from screener predictors (52,53). For item-level missing data, we used extended hot-deck multiple imputation based on the predictive mean matching method (54). We imputed five data sets, averaged results, and adjusted standard errors for imputation uncertainty (55). All variables had missingness rates of <5%, except income and MINI variables (10%−15%). All percentages reported in the results represent weighted estimates; percentages may not add to 100% because of rounding. All analyses were conducted using SUDAAN software (56). Analyses accounted for clustering (clients within programs) and weighting and were conducted to obtain parameter estimates, confidence intervals, and significance levels for the contrasts of interest.
For sensitivity analyses, we conducted parallel analysis using a version of substance abuse history status that excluded receipt of outpatient substance abuse services and self-help services, with similar conclusions. We also conducted stratified analysis for two sector subgroupings: health care (primary care and public health settings, and mental health clinics), and social-community (social services, faith-based agencies, and parks and community centers). Results had consistent direction but some changes in significance relative to main analyses. [Tables presenting results of these analyses are available in the online supplement.]

Results

Of 957 depressed participants, 217 (23%) were screened in substance abuse agencies. Of these individuals, 136 (63%) stayed overnight in a residential treatment center in the past six months, 170 (78%) had received any outpatient or self-help service for substance abuse in the past six months, 136 (63%) had drug dependence, 11 (5%) had drug abuse, 49 (23%) had alcohol dependence, and 13 (6%) had alcohol abuse.
Of the 740 participants screened in sectors other than substance abuse agencies, 269 (36%, weighted) had a recent substance abuse history. Of these, 76 (29%, weighted) had an overnight residential treatment stay in the past six months, 148 (56%, weighted) had any outpatient or self-help visit for substance abuse in the past six months, 116 (44%, weighted) had drug dependence, 15 (5%, weighted) had drug abuse, 74 (27%, weighted) had alcohol dependence, and 12 (6%, weighted) had alcohol abuse.

Sociodemographic Characteristics

Table 1 summarizes data for the depressed sample; the mean age was 45.8, and 57% were women. Race-ethnicity was as follows: Latino, 41%; African American, 46%; and white or other, 13%. Of the 957 participants, 44% had less than a high school education, and 74% had incomes under the federal poverty level. When stratified by substance abuse history status, clients varied significantly across categories on all sociodemographic characteristics other than age and income.
Table 1 Demographic characteristics of clients with depressive symptoms, by setting in which they were screened and substance abuse history statusa
Characteristic    Clients from other sectorspb
Overall (N=957)Clients from substance abuse agencies (N=217)With a substance abuse history (N=269)Without a substance abuse history (N=471)
NWeighted %NWeighted %NWeighted %NWeighted %
Age (M±SD)45.8±12.8 42.5±12.0 45.9±11.3 47.2±13.6 ns
Female56057101461234433670<.001
Married or living with partner216234923331213428<.001
Race-ethnicity        <.001
 Latino386416732782924152 
 Black or African American45646126571515417936 
 Non-Hispanic white8391683113368 
 Otherc3248494153 
Less than high school4234488401003723550.005
Born in the U.S.68070189872298526254<.001
Income under poverty level70674162752077733772ns
a
Substance abuse history (abuse or dependence) as measured by the Mini International Neuropsychiatric Interview or by use of substance abuse services in the prior 6 months from an outpatient substance abuse agency, self-help group, or residential treatment program. Data were multiply imputed at item level and percentage, and means were weighted to account for enrollment and survey response. Percentages may not add to 100% because of rounding.
b
Wald chi square test for comparison of differences across three categories, accounting for clustering (clients within programs); df=2 for all characteristics except race-ethnicity (df=6)
c
Asian or Pacific Islander, Native American, or other

Social and Clinical Needs

Table 2 shows that participants screened in substance abuse agencies had lower rates of homelessness, higher rates of arrests or probation, and greater physical health–related quality of life (PCS-12) than clients with a recent substance abuse history who were screened in other sectors. However, no significant differences were found between these groups in a wide range of socioeconomic, social, or health indicators. Overall physical, mental, and social needs were high for both groups.
Table 2 Social and clinical characteristics of clients with depressive symptoms, by setting in which they were screened and substance abuse history statusa
Variable  Clients from other sectors  
Clients from substance abuse agencies (a)With a substance abuse history (b)Without a substance abuse history (c)p
Estimate95% CIEstimate95% CIEstimate95% CI(b) versus (a)(c) versus (b)
Social        
 Has health insurance (%)34.521.9–47.142.533.8–51.152.645.3–59.9ns.011
 Homeless (%)9.03.8–14.328.116.6–39.516.08.8–23.1.002.006
 Currently employed (%)10.15.8–14.415.19.4–20.827.222.1–32.4ns<.001
 Arrested or on probation at any time in past 6 months (%)42.533.6–51.321.214.1–28.26.93.5–10.3<.001<.001
 Evicted or had house foreclosed in past 6 months (%)21.213.9–28.614.39.0–19.712.68.7–16.4nsns
 Witnessed someone being beaten, abused, or killed in past 6 months (%)19.413.2–25.621.016.1–25.910.87.2–14.3ns.001
 Lost custody of any children in past 6 months (%)9.14.6–13.64.2.8–7.61.7.6–2.8nsns
Clinical        
 PHQ-8 score (mean)b15.214.6–15.915.414.8–16.014.914.4–15.4nsns
 Number of chronic conditions (from list of 18) (mean)3.12.6–3.63.43.1–3.83.53.1–3.9nsns
 N cigarettes smoked per day in past 7 days (mean)6.95.3–8.56.65.4–7.83.42.4–4.4ns<.001
 Quality of life and functioning (mean)c        
  General3.43.2–3.63.53.4–3.63.83.6–3.9ns.001
  PCS-1240.439.4–41.438.737.9–39.639.138.3–39.9.008ns
  MCS-1239.038.1–39.938.838.0–39.539.638.8–40.4nsns
 Probable mental health diagnosis        
  Current major depressive episode or dysthymia (%)d53.745.4–61.962.756.6–68.745.539.6–51.4ns<.001
 12-month depressive disorder (%)d64.657.5–71.773.667.3–79.854.848.7–60.8ns<.001
 Lifetime psychosis or mania (%)e54.746.8–62.653.445.7–61.227.720.3–35.1ns<.001
 Any current or recent anxiety disorder (%)f55.650.1–61.156.848.0–65.738.933.2–44.7ns<.001
 Probable substance abuse diagnosis        
  Misused any drugs in past 12 months (%)66.859.3–74.253.747.3–60.09.76.3–13.0.012<.001
  AUDIT-C score (mean)g2.41.9–2.92.21.8–2.61.2.9–1.4ns<.001
  Hazardous drinker or alcohol use disorder (%)29.324.3–34.432.925.7–40.015.411.3–19.5ns<.001
a
Adjusted analyses used multiply imputed data; data were weighted to account for enrollment and survey response. Logistic regression models for binary variables or linear regression models for continuous variables adjusted for age and sex and accounted for clustering (clients within programs).
b
Eight-item Patient Health Questionnaire. Possible scores range from 0 to 24, with higher scores indicating increased depression symptoms.
c
As measured by the 12-item Short-Form Health Survey. PCS, physical component summary; MCS, mental component summary. For general health, possible scores range from 1 to 5, with higher scores indicating poorer self-rated general health. For the PCS and MCS, possible scores range from 0 to 100, with higher scores indicating better health.
d
As measured by the Mini International Neuropsychiatric Interview (MINI)
e
As measured by the MINI and from information provided at the baseline interview
f
As measured by the MINI. Panic attacks, posttraumatic stress disorder, and social anxiety disorder
g
Alcohol Use Disorders Identification Test (screen for hazardous drinking). Hazardous drinking is indicated by a score of ≥4 for males and ≥3 for females.
Among clients screened at non–substance abuse sites, clients with a substance abuse history reported lower rates of health insurance and employment than those without a substance abuse history; they also had higher rates of homelessness, arrests or probation, and witnessing violence; higher rates of tobacco use; higher rates of depression, anxiety, and lifetime psychosis or mania; and lower self-rated general health. But the two groups did not differ in mean depressive symptoms (PHQ-8), number of chronic conditions, and quality of life related to physical health or mental health (PCS-12 and MCS-12). As expected by definition, those with substance abuse histories were more likely to have substance misuse, higher AUDIT-C scores, and hazardous drinking (AUDIT-C ≥3 for women and ≥4 for men).

Use of Health Care and Depression Services

As shown in Table 3, rates of any emergency room visits and number of emergency room visits and rates of behavioral health hospitalizations were similar between clients who were screened in substance abuse agencies and those with substance abuse histories who were screened in other sectors. However, those screened in substance abuse agencies were less likely than those with substance abuse histories who were screened in other sectors to visit mental health, primary care, and social services agencies, with fewer depression-related visits in each sector.
Table 3 Use of health services by clients with depressive symptoms, by setting in which they were screened and substance abuse history statusa
Variable  Clients from other sectors  
Clients from substance abuse agencies (a)With a substance abuse history (b)Without a substance abuse history (c)p
Estimate95% CIEstimate95% CIEstimate95% CI(b) versus (a)(c) versus (b)
Emergency room        
 Any visit for any health problem in past 6 months (%)59.250.5–67.854.548.0–61.145.739.8–51.6nsns
 N of visits for any health problem in past 6 months (among 488 clients with visits) (mean)3.72.8–4.63.42.7–4.03.22.7–3.7nsns
 Any visit for alcohol, drug, or mental or emotional problem in past 6 months (%)35.929.0–42.735.429.4–41.518.413.8–22.9ns<.001
 N of visits for alcohol, drug, or mental or emotional problem (among 259 of 488 with visits) (mean)3.12.4–3.72.92.4–3.42.82.1–3.5nsns
Hospitalization for alcohol, drug, or mental or emotional problem        
 Any overnight stay in past 6 months (%)20.913.8–28.021.416.4–26.47.04.5–9.4ns<.001
 Length of stay in past 6 months (among 134 clients with stays) (mean)10.62.9–18.39.77.2–12.39.85.1–14.5nsns
Mental health specialty        
 Any visit in past 6 months (%)56.649.5–63.773.264.8–81.548.739.4–58.0.005<.001
 N of visits (among 554 clients with visits)16.511.3–21.714.011.1–16.811.09.4–12.7ns.04
 Any medication or counseling for emotional or mental health problem in past 6 months (%)55.648.6–62.569.560.9–78.144.735.7–53.7.017<.001
Primary care        
 Any visit for any problem in past 6 months (%)58.748.3–69.172.264.7–79.672.768.2–77.1.034ns
 N of visits in past 6 months (among 659 clients with visits) (mean)7.23.6–10.86.85.7–7.95.04.4–5.6ns.006
 Any visit that included a service for depression (among 659 clients with visits) (%)59.549.7–69.369.062.5–75.655.947.9–63.9ns.009
Social services agency        
 Any visit in past 6 months (%)53.147.2–59.066.258.4–74.048.942.7–55.2.012<.001
 Any visit that included a service for depression (among 522 clients with visit (%)47.436.4–58.362.856.1–69.445.037.3–52.7.02.001
Faith based (for example, church or temple)        
 Any visit in past 6 months (%)54.843.6–66.054.948.9–60.864.059.2–68.8ns.014
 Any visit that included a service for depression in past 6 months (among 568 clients with visits) (%)46.335.0–57.643.034.1–51.833.527.5–39.5nsns
Parks and community centers (including senior centers)        
 Any visit in past 6 months (%)48.543.8–53.150.042.8–57.246.240.7–51.7nsns
 Any visit that included a service for depression (among 462 clients with visits (%)11.77.3–16.122.714.6–30.813.48.5–18.3.011.047
a
Adjusted analyses used multiply imputed data; data were weighted to account for enrollment and survey response. Logistic regression models for binary variables or log-linear regression models for count variables adjusted for age and sex and accounted for clustering (clients within programs).
In sectors other than substance abuse, clients with a recent history of substance abuse were more likely than those without such a history to visit emergency rooms and to have behavioral health hospitalizations in the past six months. Those with a recent substance abuse history were also more likely to visit mental health and social services and less likely to have faith-based visits and had more depression-related visits in all sectors other than faith-based.

Satisfaction

Most of the 957 depressed clients were satisfied with health services (N=609, 64%) and community services (N=573, 60%) that were available for emotional or mental health problems. No significant differences were found on the basis of substance abuse history or screening sector.

Discussion

CPIC provided a unique opportunity to compare social and health needs, patterns of services use, and satisfaction among clients with depressive symptoms and recent substance abuse histories in underresourced communities of color across diverse services sectors. To our knowledge, CPIC is the only study that frames depression in the context of service sectors (that is, primary care, mental health, substance abuse, homeless, and social and community services) that have been deemed by our community partners as supporting depressed clients. Most studies focus on only one or two settings.
The depressed clients in this sample were from a range of participating programs. About half of the overall sample had substance abuse histories; one quarter of the sample were identified from substance abuse sectors, and one quarter were from other sectors. Depressed clients with comorbid substance abuse made up over half of all depressed clients from other sectors. Because of the high prevalence of substance abuse histories among depressed clients, descriptive data were important to CPIC partners for services planning.
Individuals with depression and substance abuse histories in these communities had high clinical and psychosocial needs, regardless of the location in which they were screened. Most were unemployed, over half lacked health insurance, and about one-fifth had witnessed violence in the past six months. Participants had moderate to high rates of psychiatric and medical comorbidities, including tobacco use, depression, anxiety, psychosis, or mania. Of clients screened in substance abuse agencies, almost half had been arrested or had been on probation in the past six months. Of note, clients from substance use agencies had lower rates of homelessness (9%) than those from other sectors—both those with a substance abuse history (28.1%) and those without (16.0%). Our findings may reflect the impact of policy initiatives in California during the study time period decriminalizing substance abuse. This reduced recidivism by diverting individuals convicted of nonviolent drug possession from prisons into substance abuse treatment and postincarceration programs offering supportive housing and employment (57).
As expected, depressed clients who were screened in substance abuse agencies and those who were screened in other sectors who had substance abuse histories had higher rates of use of emergency rooms (5861) and were hospitalized at higher rates (6264) than depressed clients without substance abuse histories. However, individuals screened in substance abuse agencies had higher rates of service use from substance abuse agencies and lower rates of service use from other sectors. This finding may be attributable to the design of the study, which screened consecutive clients in each location, resulting in oversampling of frequent users of that location. As found in prior studies (6567), this study found that clients with substance abuse histories who were screened in other sectors were more likely than those without such histories to visit outpatient mental health clinics for depression. However, we are not aware of prior studies that have reported increased use of depression services in social services and other sectors among clients with substance abuse histories compared with those without such histories. Differences in utilization patterns within and across sectors may be attributable to distinct services referral networks in a given sector or differences in clients’ needs (6). However, it is noteworthy that the overall services utilization pattern differed depending on whether a client with a substance abuse history was identified in a substance abuse agency (a pattern of increased substance use services) or non–substance use sectors (a pattern of increased depression-related services across sectors). This suggests that each sector’s networks may be complementary.
These findings may be important as safety-net health care systems work to provide care for the complex psychosocial (for example, legal, employment, and housing), behavioral health, and general medical (6,29) needs of new Medicaid enrollees under health care reform, because the demographic profiles of these new enrollees are similar to those of clients described here. Initiatives such as accountable care organizations and Medicaid behavioral health homes (22,24) provide incentives to support collaborations across historically siloed sectors to improve outcomes (23) through evidence-based integration strategies, such as collaborative care for depression, while addressing social determinants of health, such as housing and employment. Although published models of depression care and substance abuse care that focus on primary care–mental health integration (11,29,31,68,69) have demonstrated improved patient health outcomes, they may be more difficult to implement in Health Resources and Services Administration–defined medically underserved areas with health care service shortages (70). Medically underserved communities may consider implementing models that extend clinical care through collaborations between health care, substance abuse, and other social and community sectors to deliver evidence-based depression care while also addressing clients’ social, general medical, and substance abuse needs. It is not yet known, however, whether delivery of linked services is better accomplished through centralized models (colocated services) or through distributive models (referrals) and which models enhance client outcomes (11). To implement depression or substance abuse care models across health care and non–health care settings, future research should explore whether service use and outcomes for those with depression and comorbid substance abuse differ by a client’s “home” sector and by the quality of program linkages and services within networks.
Linking general medical sectors to substance abuse and social and community sectors to increase detection and treatment of depression and substance use may be useful, particularly for case management initiatives in medically underserved communities. Clients with depression and substance abuse histories have high rates of acute care utilization (71), accounting for a disproportionately high percentage of visits and costs (72). Case management innovations for this population are currently an area of intense investigation (73,74). For example, case management services linking homeless persons to stable housing have been shown to reduce emergency room visits, hospitalizations, and costs (75). Community engagement may be one strategy to link sectors and facilitate an innovative approach to and evaluation of such efforts (33).
This study had several limitations. Generalizability of these findings to other program types or communities may be limited. We included financially stable programs in two underresourced communities of color in Los Angeles. Study recruitment was limited to programs listed in county resource guidebooks and partners’ recommendations. Although participating and nonparticipating programs served similar populations, we did not include all programs in each community. Response rates were moderate for agencies. We oversampled high users by sector, and results may not generalize to less frequent users. Data are limited to client self-report (claims data were not used). The study had a diverse sample of community services sectors and used a unique participatory approach involving agency coleadership, which may be useful as a model for communitywide health assessment and quality improvement initiatives.

Conclusions

Overall, this exploratory study showed that comorbid depression and substance abuse are common across diverse sectors that serve safety-net populations. These individuals have complex psychosocial, general medical, mental health, and substance abuse needs, and services are fragmented across sectors. Future work may utilize these findings within the context of Medicaid behavioral health homes by providing incentives for collaboration between health care and community agencies to improve access to and quality of high-value services across a network to address the complex needs of clients with comorbid depression and substance abuse.

Supplementary Material

File (appi.ps.201300318.ds001.pdf)

References

1.
Olfson M, Shea S, Feder A, et al: Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Archives of Family Medicine 9:876–883, 2000
2.
Dohrenwend BP, Levav I, Shrout PE, et al: Socioeconomic status and psychiatric disorders: the causation-selection issue. Science 255:946–952, 1992
3.
Kessler RC, McGonagle KA, Zhao S, et al: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry 51:8–19, 1994
4.
Ialongo N, McCreary BK, Pearson JL, et al: Major depressive disorder in a population of urban, African-American young adults: prevalence, correlates, comorbidity and unmet mental health service need. Journal of Affective Disorders 79:127–136, 2004
5.
Bruce ML, Takeuchi DT, Leaf PJ: Poverty and psychiatric status: longitudinal evidence from the New Haven Epidemiologic Catchment Area study. Archives of General Psychiatry 48:470–474, 1991
6.
Adaptation to Mental Health and Addictive Disorders: Improving the Quality of Health Care for Mental and Substance-Use Conditions. Washington, DC, National Academies Press, 2006
7.
Flynn PM, Brown BS: Co-occurring disorders in substance abuse treatment: issues and prospects. Journal of Substance Abuse Treatment 34:36–47, 2008
8.
McGovern MP, Xie H, Segal SR, et al: Addiction treatment services and co-occurring disorders: prevalence estimates, treatment practices, and barriers. Journal of Substance Abuse Treatment 31:267–275, 2006
9.
Cristofalo M, Boutain D, Schraufnagel TJ, et al: Unmet need for mental health and addictions care in urban community health clinics: frontline provider accounts. Psychiatric Services 60:505–511, 2009
10.
Hien D, Zimberg S, Weisman S, et al: Dual diagnosis subtypes in urban substance abuse and mental health clinics. Psychiatric Services 48:1058–1063, 1997
11.
Samet JH, Friedmann P, Saitz R: Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Archives of Internal Medicine 161:85–91, 2001
12.
Mojtabai R, Olfson M, Mechanic D: Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Archives of General Psychiatry 59:77–84, 2002
13.
Benjamin-Johnson R, Moore A, Gilmore J, et al: Access to medical care, use of preventive services, and chronic conditions among adults in substance abuse treatment. Psychiatric Services 60:1676–1679, 2009
14.
Larson MJ, Saitz R, Horton NJ, et al: Emergency department and hospital utilization among alcohol and drug-dependent detoxification patients without primary medical care. American Journal of Drug and Alcohol Abuse 32:435–452, 2006
15.
Wenzel SL, Burnam MA, Koegel P, et al: Access to inpatient or residential substance abuse treatment among homeless adults with alcohol or other drug use disorders. Medical Care 39:1158–1169, 2001
16.
Padgett D, Struening EL, Andrews H: Factors affecting the use of medical, mental health, alcohol, and drug treatment services by homeless adults. Medical Care 28:805–821, 1990
17.
Koegel P, Sullivan G, Burnam A, et al: Utilization of mental health and substance abuse services among homeless adults in Los Angeles. Medical Care 37:306–317, 1999
18.
Harris KM, Edlund MJ: Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatric Services 56:954–959, 2005
19.
Watkins KE, Burnam A, Kung F-Y, et al: A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatric Services 52:1062–1068, 2001
20.
Watkins KE, Hunter SB, Burnam MA, et al: Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder. Psychiatric Services 56:913–926, 2005
21.
Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41. Rockville, Md, Substance Abuse and Mental Health Services Administration, 2011
22.
Bao Y, Casalino LP, Pincus HA: Behavioral health and health care reform models: patient-centered medical home, health home, and accountable care organization. Journal of Behavioral Health Services and Research 40:121–132, 2013
23.
Alakeson V, Frank RG, Katz RE: Specialty care medical homes for people with severe, persistent mental disorders. Health Affairs 29:867–873, 2010
24.
Mechanic D: Seizing opportunities under the Affordable Care Act for transforming the mental and behavioral health system. Health Affairs 31:376–382, 2012
25.
SAMHSA Position on Treatment for Individuals with Co-occurring Addictive and Mental Disorders. Rockville, Md, Substance Abuse and Mental Health Services Administration, 1999
26.
Samet JH, Larson MJ, Horton NJ, et al: Linking alcohol- and drug-dependent adults to primary medical care: a randomized controlled trial of a multi-disciplinary health intervention in a detoxification unit. Addiction 98:509–516, 2003
27.
Druss BG, von Esenwein SA, Compton MT, et al: A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. American Journal of Psychiatry 167:151–159, 2010
28.
Druss BG, von Esenwein SA: Improving general medical care for persons with mental and addictive disorders: systematic review. General Hospital Psychiatry 28:145–153, 2006
29.
Butler M, Kane RL, McAlpine D, et al: Integration of Mental Health/Substance Abuse and Primary Care. Rockville, Md, Agency for Healthcare Research and Quality, 2008
30.
Mental Health, and Substance Use Services Integration Policy Initiative. Sacramento, California Institute for Mental Health, 2009
31.
Collins C, Hewson DL, Munger R, et al: Evolving Models of Behavioral Health Integration in Primary Care. New York, Milbank Memorial Fund, 2010
32.
Burnam MA, Watkins KE: Substance abuse with mental disorders: specialized public systems and integrated care. Health Affairs 25:648–658, 2006
33.
Chung B, Jones L, Dixon EL, et al: Using a community partnered participatory research approach to implement a randomized controlled trial: planning community partners in care. Journal of Health Care for the Poor and Underserved 21:780–795, 2010
34.
Miranda J, Ong MK, Jones L, et al: Community-partnered evaluation of depression services for clients of community-based agencies in under-resourced communities in Los Angeles. Journal of General Internal Medicine 28:1279–1287, 2013
35.
Katz DL, Murimi M, Gonzalez A, et al: From controlled trial to community adoption: the multisite translational community trial. American Journal of Public Health 101:e17–e27, 2011
36.
Khodyakov D, Sharif MZ, Dixon EL, et al: An implementation evaluation of the community engagement and planning intervention in the CPIC Depression Care Improvement Trial. Community Mental Health Journal 50:312–324, 2014
37.
Wells KB, Jones L, Chung B, et al: Community-partnered cluster-randomized comparative effectiveness trial of community engagement and planning or resources for services to address depression disparities. Journal of General Internal Medicine 28:1268–1278, 2013
38.
Community Partners in Care: 6-Month Client Outcomes, Protocol. Los Angeles, Semel Institute for Neuroscience and Human Behavior, 2012. Available at hss.semel.ucla.edu/documents/CPIC_Protocol_Dec2012.pdf
39.
Bluthenthal RN, Jones L, Fackler-Lowrie N, et al: Witness for Wellness: preliminary findings from a community-academic participatory research mental health initiative. Ethnicity and Disease 16(suppl 1):S18–S34, 2006
40.
Dossett E, Fuentes S, Klap R, et al: Obstacles and opportunities in providing mental health services through a faith-based network in Los Angeles. Psychiatric Services 56:206–208, 2005
41.
Key Indicators of Health by Service Planning Area. Los Angeles, County Department of Public Health¸ June 2009
42.
2011 Greater Los Angeles Homeless Count Report. Los Angeles, Los Angeles Homeless Services Authority, Aug 2011
43.
Kroenke K, Strine TW, Spitzer RL, et al: The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders 114:163–173, 2009
44.
Bruce ML, Ten Have TR, Reynolds CF 3rd, et al: Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA 291:1081–1091, 2004
45.
Wells KB, Sherbourne C, Schoenbaum M, et al: Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA 283:212–220, 2000
46.
Oslin DW, Sayers S, Ross J, et al: Disease management for depression and at-risk drinking via telephone in an older population of veterans. Psychosomatic Medicine 65:931–937, 2003
47.
Unützer J, Katon W, Williams JW Jr, et al: Improving primary care for depression in late life: the design of a multicenter randomized trial. Medical Care 39:785–799, 2001
48.
Ware J Jr, Kosinski M, Keller SD: A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care 34:220–233, 1996
49.
Sheehan DV, Lecrubier Y, Sheehan KH, et al: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59(suppl 20):22–33, 1998
50.
Bush K, Kivlahan DR, McDonell MB, et al: The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Archives of Internal Medicine 158:1789–1795, 1998
51.
Graubard BI, Korn EL: Predictive margins with survey data. Biometrics 55:652–659, 1999
52.
Korn EL, Graubard BI: Analysis of Health Surveys. Hoboken, NJ, Wiley-Interscience, 1999
53.
Groves RM, Dillman D, Eltinge JL, et al: Survey Nonresponse. Hoboken, NJ, Wiley-Interscience, 2002
54.
Little R: Missing data adjustments in large surveys. Journal of Business and Economic Statistics 6:287–301, 1988
55.
Rubin D: Multiple Imputation for Non-Response in Surveys. New York, Wiley, 1987
56.
SUDAAN 10.0. Research Triangle Park, NC, RTI International, 2012
57.
Status of Ex-Offender Reentry Efforts in Cities: a 79-city Survey; in 2009 Survey and Best Practice. Washington, DC, United States Conference of Mayors, 2009
58.
Doupe MB, Palatnick W, Day S, et al: Frequent users of emergency departments: developing standard definitions and defining prominent risk factors. Annals of Emergency Medicine 60:24–32, 2012
59.
Doran KM, Raven MC, Rosenheck RA: What drives frequent emergency department use in an integrated health system? National data from the Veterans Health Administration. Annals of Emergency Medicine 62:151–159, 2013
60.
Cherpitel CJ, Ye Y: Trends in alcohol- and drug-related ED and primary care visits: data from three US National Surveys (1995–2005). American Journal of Drug and Alcohol Abuse 34:576–583, 2008
61.
Pasic J, Russo J, Roy-Byrne P: High utilizers of psychiatric emergency services. Psychiatric Services 56:678–684, 2005
62.
Walley AY, Paasche-Orlow M, Lee EC, et al: Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. Journal of Addiction Medicine 6:50–56, 2012
63.
Billings J, Mijanovich T: Improving the management of care for high-cost Medicaid patients. Health Affairs 26:1643–1654, 2007
64.
Dilonardo J, Coffey R, Vandivort-Warren R, et al: Inpatient utilization for persons with co-occurring disorders. Psychiatric Services 59:14, 2008
65.
Hoff RA, Rosenheck RA: The cost of treating substance abuse patients with and without comorbid psychiatric disorders. Psychiatric Services 50:1309–1315, 1999
66.
Wu LT, Kouzis AC, Leaf PJ: Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. American Journal of Psychiatry 156:1230–1236, 1999
67.
Ross HE, Lin E, Cunningham J: Mental health service use: a comparison of treated and untreated individuals with substance use disorders in Ontario. Canadian Journal of Psychiatry 44:570–577, 1999
68.
An Integrated Framework for Assessing the Value of Community-Based Prevention. Washington, DC, National Academies Press, 2012
69.
Mertens JR, Lu YW, Parthasarathy S, et al: Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Archives of Internal Medicine 163:2511–2517, 2003
70.
Shortage Designation: Health Professional Shortage Areas and Medically Underserved Areas/Populations. Washington, DC, US Department of Health and Human Services, Health Resources and Services Administration, 2014
71.
Yoon J, Yano EM, Altman L, et al: Reducing costs of acute care for ambulatory care-sensitive medical conditions: the central roles of comorbid mental illness. Medical Care 50:705–713, 2012
72.
Watkins KE, Pincus HA, Paddock S, et al: Care for veterans with mental and substance use disorders: good performance, but room to improve on many measures. Health Affairs 30:2194–2203, 2011
73.
Hasselman D: Super-Utilizer Summit: Common Themes From Innovative Complex Care Management Programs. Hamilton, NJ, Center for Health Care Strategies, 2013
74.
Mann C: Reducing Nonurgent Use of Emergency Departments and Improving Appropriate Care in Appropriate Settings Baltimore. Centers for Medicare and Medicaid Services, 2014
75.
Sadowski LS, Kee RA, VanderWeele TJ, et al: Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial. JAMA 301:1771–1778, 2009

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: March Thaw, by Willard L. Metcalf, 1922. Oil on canvas. Collection of the Newark Museum, Newark, NJ, bequest of Diane Bonner Lewis, 1988, inv. 88.12. Photo credit: Newark Museum/Art Resource, New York City.

Psychiatric Services
Pages: 285 - 294
PubMed: 25727117

History

Published online: 1 December 2014
Published in print: March 01, 2015

Authors

Details

Evelyn T. Chang, M.D., M.S.H.S.
Dr. Chang is with the Department of General Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles (e-mail: [email protected]). Dr. Wells, Dr. Tang, and Dr. Chung are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Wells and Dr. Chung conducted this work in their roles with the RAND Corporation. Mr. Gilmore is with Behavioral Health Services, Inc., Los Angeles, California. Dr. Morgan is with the Division of General Internal Medicine, Harbor–UCLA Medical Center, Los Angeles. Ms. Sanders is with The House of Uhuru, Los Angeles. A summary of these findings was presented at a meeting of the California-Hawaii Regional Society of General Internal Medicine, Los Angeles, February 2, 2013, and at a meeting of the AcademyHealth Behavioral Health Interest Group, Baltimore, June 22, 2013.
Kenneth B. Wells, M.D., M.P.H.
Dr. Chang is with the Department of General Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles (e-mail: [email protected]). Dr. Wells, Dr. Tang, and Dr. Chung are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Wells and Dr. Chung conducted this work in their roles with the RAND Corporation. Mr. Gilmore is with Behavioral Health Services, Inc., Los Angeles, California. Dr. Morgan is with the Division of General Internal Medicine, Harbor–UCLA Medical Center, Los Angeles. Ms. Sanders is with The House of Uhuru, Los Angeles. A summary of these findings was presented at a meeting of the California-Hawaii Regional Society of General Internal Medicine, Los Angeles, February 2, 2013, and at a meeting of the AcademyHealth Behavioral Health Interest Group, Baltimore, June 22, 2013.
James Gilmore, M.B.A.
Dr. Chang is with the Department of General Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles (e-mail: [email protected]). Dr. Wells, Dr. Tang, and Dr. Chung are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Wells and Dr. Chung conducted this work in their roles with the RAND Corporation. Mr. Gilmore is with Behavioral Health Services, Inc., Los Angeles, California. Dr. Morgan is with the Division of General Internal Medicine, Harbor–UCLA Medical Center, Los Angeles. Ms. Sanders is with The House of Uhuru, Los Angeles. A summary of these findings was presented at a meeting of the California-Hawaii Regional Society of General Internal Medicine, Los Angeles, February 2, 2013, and at a meeting of the AcademyHealth Behavioral Health Interest Group, Baltimore, June 22, 2013.
Lingqi Tang, Ph.D.
Dr. Chang is with the Department of General Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles (e-mail: [email protected]). Dr. Wells, Dr. Tang, and Dr. Chung are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Wells and Dr. Chung conducted this work in their roles with the RAND Corporation. Mr. Gilmore is with Behavioral Health Services, Inc., Los Angeles, California. Dr. Morgan is with the Division of General Internal Medicine, Harbor–UCLA Medical Center, Los Angeles. Ms. Sanders is with The House of Uhuru, Los Angeles. A summary of these findings was presented at a meeting of the California-Hawaii Regional Society of General Internal Medicine, Los Angeles, February 2, 2013, and at a meeting of the AcademyHealth Behavioral Health Interest Group, Baltimore, June 22, 2013.
Anna U. Morgan, M.D.
Dr. Chang is with the Department of General Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles (e-mail: [email protected]). Dr. Wells, Dr. Tang, and Dr. Chung are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Wells and Dr. Chung conducted this work in their roles with the RAND Corporation. Mr. Gilmore is with Behavioral Health Services, Inc., Los Angeles, California. Dr. Morgan is with the Division of General Internal Medicine, Harbor–UCLA Medical Center, Los Angeles. Ms. Sanders is with The House of Uhuru, Los Angeles. A summary of these findings was presented at a meeting of the California-Hawaii Regional Society of General Internal Medicine, Los Angeles, February 2, 2013, and at a meeting of the AcademyHealth Behavioral Health Interest Group, Baltimore, June 22, 2013.
Starr Sanders, C.A.S.
Dr. Chang is with the Department of General Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles (e-mail: [email protected]). Dr. Wells, Dr. Tang, and Dr. Chung are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Wells and Dr. Chung conducted this work in their roles with the RAND Corporation. Mr. Gilmore is with Behavioral Health Services, Inc., Los Angeles, California. Dr. Morgan is with the Division of General Internal Medicine, Harbor–UCLA Medical Center, Los Angeles. Ms. Sanders is with The House of Uhuru, Los Angeles. A summary of these findings was presented at a meeting of the California-Hawaii Regional Society of General Internal Medicine, Los Angeles, February 2, 2013, and at a meeting of the AcademyHealth Behavioral Health Interest Group, Baltimore, June 22, 2013.
Bowen Chung, M.D., M.S.H.S.
Dr. Chang is with the Department of General Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles (e-mail: [email protected]). Dr. Wells, Dr. Tang, and Dr. Chung are with the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Wells and Dr. Chung conducted this work in their roles with the RAND Corporation. Mr. Gilmore is with Behavioral Health Services, Inc., Los Angeles, California. Dr. Morgan is with the Division of General Internal Medicine, Harbor–UCLA Medical Center, Los Angeles. Ms. Sanders is with The House of Uhuru, Los Angeles. A summary of these findings was presented at a meeting of the California-Hawaii Regional Society of General Internal Medicine, Los Angeles, February 2, 2013, and at a meeting of the AcademyHealth Behavioral Health Interest Group, Baltimore, June 22, 2013.

Funding Information

National Institute of Mental Health10.13039/100000025: P30MH068639, P30MH082760, R01MH078853
National Center for Advancing Translational Sciences10.13039/100006108: UL1TR000124
California Community Foundation10.13039/100001017: CMCH-12-97088
Robert Wood Johnson Foundation10.13039/100000867: 64244
Funding was provided through the Health Services Fellowship Training Program (TMP 65-020) by the Office of Academic Affiliations, Health Services Research and Development, U.S. Department of Veterans Affairs (VA). The study was also funded by awards R01MH078853, P30MH082760, and P30MH068639 from the National Institute of Mental Health (NIMH); award 64244 from the Robert Wood Johnson Foundation; award UL1TR000124 from the UCLA Clinical and Translational Science Institute, National Center for Advancing Translational Science; and award CMCH-12-97088 from the California Community Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the VA; NIMH; National Institutes of Health; UCLA Clinical and Translational Science Institute, National Center for Advancing Translational Science; California Community Foundation; or other affiliated institutions. Community Partners in Care is registered at clinical trials.gov (NCT01699789). The authors thank the 50 participating agencies and their representatives, the participating Los Angeles programs and their providers and staff, and the clients who participated. A list of community partners is at www.communitypartnersincare.org/about/partners. The authors thank the RAND Survey Research Group and trained community members who conducted client data collection. They also thank Wayne Aoki, Ph.D., for comments on the manuscript.The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share